Information Provided By:
Fly News Breaks for May 24, 2019
DRNA
May 24, 2019 | 07:24 EDT
Citi analyst Yigal Nochomovitz assumed coverage of Dicerna Pharmaceuticals with a Buy rating and $30 price target.
News For DRNA From the Last 2 Days
There are no results for your query DRNA